Indonesian mob slaughters ‘hundreds’ of crocs in revenge attack

Local residents look at the carcasses of hundreds of crocodiles from a farm after they were killed by angry locals following the death of a man who was killed in a crocodile attack. (Antara Foto/Olha Mulalinda/Reuters)
Updated 16 July 2018

Indonesian mob slaughters ‘hundreds’ of crocs in revenge attack

  • The victim, identified as 48-year-old Sugito, was bitten on the leg and then fatally struck
  • The mob headed to the crocodile farm armed with knives, machetes and shovels

SORONG: An angry mob has slaughtered nearly 300 crocodiles in Indonesia after a local man was killed by one of the reptiles, authorities said Monday.
The revenge killing happened Saturday in Papua province following the funeral of the man, who perished when he fell into an enclosure at a crocodile farm while looking for grass to feed his livestock, police and conservation officials said.
The victim, identified as 48-year-old Sugito, was bitten on the leg and then fatally struck with a tail of one of the crocodiles, which are a protected species, they said.
Sugito’s relatives and local residents, angry over the farm’s location near a residential area, marched to the local police station, authorities said.
Local conservation agency head Bassar Manulang said they were told that the farm had agreed to pay compensation.
“We made an agreement with the victim’s family and conveyed our condolences,” he added.
But the mob, which numbered in the “hundreds,” was not satisfied and headed to the crocodile farm armed with knives, machetes and shovels which they used to slaughter some 292 crocs, from four-inch-long babies to two-meter adults, authorities said.
Outnumbered police and conservation agency officials said they were unable to stop the grisly attack.
Authorities said they are investigating and may lay criminal charges.
“For now we are still questioning the witnesses,” said Dewa Made Sidan Sutrahna, the police chief in Papua’s Sorong district.
The Indonesian archipelago is home to a vast array of wildlife, including several species of crocodile that regularly attack and kill humans.
In March, authorities in the Indonesian half of Borneo island shot and killed a six-meter long crocodile after it ate a local palm plantation worker.
Two years ago, a Russian tourist was killed by a crocodile in the Raja Ampat islands, a popular diving site in the east of the archipelago.


US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

Updated 46 min 42 sec ago

US to pay over $1bn for 100m doses of J&J’s potential COVID-19 vaccine

  • The latest contract equates to roughly $10 per vaccine dose produced by J&J
  • This is J&J’s first deal to supply its investigational vaccine to a country

WASHINGTON: The United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
It said it would deliver the vaccine to the Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the US Food and Drug Administration (FDA).
J&J has already received $1 billion in funding from the US government — BARDA agreed in March to provide that money for the company to build manufacturing capacity for more than 1 billion doses of the experimental vaccine.
The latest contract equates to roughly $10 per vaccine dose produced by J&J. Including the first $1 billion deal with the USgovernment, the price would be slightly higher than the $19.50 per dose that the United States is paying for the vaccine being developed by Pfizer Inc. and German biotech BioNTech SE.
The US government may also purchase an additional 200 million doses under a subsequent agreement. J&J did not disclose that deal’s value.
J&J plans to study a one- or two-dose regimen of the vaccine in parallel later this year. A single-shot regimen could allow more people to be vaccinated with the same number of doses and would sidestep issues around getting people to come back for their second dose.
This is J&J’s first deal to supply its investigational vaccine to a country. Talks are underway with the European Union, but no deal has yet been reached.
J&J’s investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early-stage study.
There are currently no approved vaccines for COVID-19. More than 20 are in clinical trials.